VTGN Stock Analysis: Buy, Sell, or Hold?
VTGN - Vistagen Therapeutics, Inc. Common Stock
$0.65
0.02 (2.45%)
▲
5d:
-6.12%
30d:
+0.12%
90d:
+5.11%
HOLD
LOW Confidence
Analysis Updated: Jun 23, 2026 12:00 AM ET
Earnings: Aug 06, 2026
Get Alerted When VTGN Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: VTGN shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: VTGN shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: VTGN is currently trading at $0.65, which is considered fair relative to its 30-day fair value range of $0.56 to $0.66.
Technical Outlook: Technically, VTGN is showing sideways momentum. The price is approaching resistance at $0.66. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: VTGN has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $0.97 (+52.9%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, VTGN is showing sideways momentum. The price is approaching resistance at $0.66. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: VTGN has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $0.97 (+52.9%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$0.56 -
$0.66
Company Quality Score
59/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
86.8%
All Signals
- NEUTRAL: Price in fair range
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 52.9% below Wall St target ($0.97)
- CAUTION: Recommendation downgraded due to -6.1% 5-day decline
Trading Range Analysis
30-Day Trading Range
$0.56 -
$0.66
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$0.52
Resistance Level
$0.66
Current Trend
Sideways
Technical data as of
Jun 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-0.65
Wall Street Target
$0.97
(+52.9%)
Revenue Growth (YoY)
29.5%
Share & Embed Analysis
Last updated: June 24, 2026 12:40 PM ET
Data refreshes hourly during market hours. Next update: 1:40 PM
Data refreshes hourly during market hours. Next update: 1:40 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is VTGN showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical … |
STRONG BUY
29 analysts |
$88 | 65 BUY |
|
ALNY
Alnylam Pharmaceuticals … |
STRONG BUY
30 analysts |
$436 | 54 HOLD |
|
VRTX
Vertex Pharmaceuticals I… |
BUY
34 analysts |
$549 | 67 BUY |
|
CRSP
Crispr Therapeutics AG |
BUY
28 analysts |
$84 | 59 HOLD |
|
LEGN
Legend Biotech Corp |
STRONG BUY
22 analysts |
$58 | 52 HOLD |
